NCT06471556 - Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2029

Conditions

Neuroendocrine Cell Hyperplasia of Infancy

Interventions

DRUG

IV Methylprednisolone pulses

Six (6) pulses (max) are performed at a 4 weeks interval (+/- 10 days). Each pulse is a 3-days-6h-perfusions of Methylprednisolone (500mg and 120mg) 10mg/kg/day diluted in 50ml of saline under supervision of SpO2, heart rate, blood pressure /

Trial Locations (1)

75012

RECRUITING

Pediatric Pulmonology Department and Reference centre for rare lung diseases, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER